Contrast agents for hepatic MRI. (Q36963721)

17 August 2017

3 references

7 August 2020

9 September 2020

Contrast agents for hepatic MRI. (English)

1 reference

magnetic resonance imaging

17 August 2017

1 reference

7 August 2020

2 references

7 August 2020

9 September 2020

1 reference

9 September 2020

1

Giovanni Morana

1 reference

17 August 2017

Elisabetta Salviato

2

1 reference

PMC publication ID

2727962

17 August 2017

Alessandro Guarise

series ordinal

3

1 reference

17 August 2017

1 October 2007

3 references

17 August 2017

7 August 2020

9 September 2020

3 references

17 August 2017

7 August 2020

9 September 2020

7 Spec No A

1 reference

17 August 2017

S24-7

1 reference

Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

Hepatic adenomas: imaging and pathologic findings

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

Liver-specific MR imaging contrast agents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

MR cholangiography with manganese dipyridoxyl diphosphate in the evaluation of biliary-enteric anastomoses: preliminary experience

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

Gadobenate dimeglumine (Gd-BOPTA). An overview

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

Superparamagnetic iron oxide: pharmacokinetics and toxicity

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727962

Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T

4 September 2018

1 reference

12 December 2020

Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging

1 reference

12 December 2020

Biliary excretion and pharmacokinetics of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging in the rat

1 reference

12 December 2020

Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images

1 reference

12 December 2020

Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging

1 reference

12 December 2020

Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application

1 reference

12 December 2020

Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA

1 reference

12 December 2020

Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP)

1 reference

12 December 2020

MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies

1 reference

12 December 2020

Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation

1 reference

12 December 2020

Diagnosis of liver metastases from colorectal adenocarcinoma

1 reference

12 December 2020

[T1-weighted dynamic MRI with new superparamagnetic iron oxide particles (Resovist): results of a phantom study as well as 25 patients]

1 reference

12 December 2020

Multihance clinical pharmacology: biodistribution and MR enhancement of the liver

1 reference

12 December 2020

Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging

1 reference

12 December 2020

Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers

1 reference

12 December 2020

Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA)

1 reference

12 December 2020

MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment

1 reference

12 December 2020

Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging

1 reference

12 December 2020

Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A)

1 reference

12 December 2020

Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers

1 reference

12 December 2020

Hepatobiliary MR imaging: first human experience with MnDPDP

1 reference

12 December 2020

Superparamagnetic iron oxide: clinical time-response study

1 reference

12 December 2020

10.1102/1470-7330.2007.9001

Identifiers

DOI

1 reference

17 August 2017

1 reference

PMC publication ID

2727962

17 August 2017

PubMed publication ID

17921081

1 reference

PMC publication ID

2727962